How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,203 results for

Fetal Tachycardia

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia

2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies (...) . By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society , MD, FACC, FAHA, FHRS, Chair , MD, FACC, FAHA, FHRS, Vice Chair , RN, MBA, PhD, FAHA , MD, FACC, FAHA, FHRS , MD, FACC , MD , MD, FACC

2015 American Heart Association

22. Morphine-induced supraventricular tachycardia in near-term fetus (PubMed)

Morphine-induced supraventricular tachycardia in near-term fetus Fetal supraventricular tachycardia (SVT), characterized by fetal heart rate between 220 and 260 bpm, is a rare but most commonly encountered fetal cardiac arrhythmia in pregnancy that may be associated with adverse perinatal outcome.We describe a 36/6 week near term fetus who presented morphine-induced SVT after maternal treatment of a renal colic. Following emergency cesarean section, the neonate had resolution of symptoms.The

Full Text available with Trip Pro

2018 Italian journal of pediatrics

23. Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. (PubMed)

; perinatal mortality; fetal hypoxia; fetal tachycardia) or on any of the reviews neonatal or maternal outcomes.There is insufficient evidence to confirm or refute the effectiveness of caffeine avoidance on birthweight or other pregnancy outcomes. There is a need to conduct high-quality, double-blinded RCTs to determine whether caffeine has any effect on pregnancy outcome. (...) Effects of restricted caffeine intake by mother on fetal, neonatal and pregnancy outcomes. Maternal caffeine consumption during pregnancy may have adverse effects on fetal, neonatal and maternal outcomes.This review investigates the effects of restricting caffeine intake by mothers on fetal, neonatal and pregnancy outcomes.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (16 January 2015), scanned bibliographies of published studies and corresponded

2015 Cochrane

24. Concurrent maternal and fetal tachyarrhythmia in pregnancy (PubMed)

Concurrent maternal and fetal tachyarrhythmia in pregnancy The occurrence of a maternal and fetal tachyarrhythmia together in pregnancy is exceedingly rare. We report a case of a persistent fetal atrial ectopic tachycardia occurring in conjunction with a maternal atrial tachycardia with left ventricular systolic dysfunction. Amiodarone was effective in treating both maternal and fetal arrhythmias.

Full Text available with Trip Pro

2017 Obstetric medicine

25. Left ventricular non-compaction cardiomyopathy with coronary artery anomaly complicated by ventricular tachycardia. (PubMed)

Left ventricular non-compaction cardiomyopathy with coronary artery anomaly complicated by ventricular tachycardia. Non-compaction cardiomyopathy (NCCM) is characterized by prominent trabeculations, deep intertrabecular recesses, and a thick non-compacted endocardial myocardium. Prevalence in the general population remains unclear, but echocardiography series report 0.05%. During fetal development muscle fibers and trabeculae should compact into a solid myocardium and when this fails, NCCM (...) 35% despite optimal pharmacological therapy, an implantable cardioverter defibrillator (ICD) was implanted and four years later a ventricular tachycardia was terminated by antitachycardia pacing.We describe a case of NCCM with a concomitant coronary anomaly, in which systolic myocardial dysfunction developed. The ICD subsequently terminated a life-threatening ventricular arrhythmia, which supports risk stratification based on low ejection fraction and possibly coronary anomaly.

Full Text available with Trip Pro

2017 BMC Cardiovascular Disorders

26. Usefulness of Routine Transtelephonic Monitoring for Supraventricular Tachycardia in Infants. (PubMed)

Usefulness of Routine Transtelephonic Monitoring for Supraventricular Tachycardia in Infants. We hypothesize that routine daily transtelephonic monitoring (TTM) transmissions can accurately detect supraventricular tachycardia (SVT) in asymptomatic infants and/or assuage parental concerns rather than being used solely to diagnose arrhythmias.Single center, retrospective chart review of 60 patients with fetal or infant SVT prescribed TTM for at least 30 days, January 2010-September 2016. Patients (...) were excluded if initial SVT was not documented, was perioperative, was atrial flutter/fibrillation, or chaotic atrial tachycardia. Categorical variables expressed as mean ± SD. Mann-Whitney, Spearman correlation, and Fisher exact tests were used for continuous and categorical variables respectively.Sixty patients were included. There were 2688 TTM transmissions received from 55 of 60 patients over 61.1 ± 66.7 days (0.73 ± 0.65 TTM/patient/days). Routine asymptomatic TTM transmissions revealed

2017 Journal of Pediatrics

27. Intraoperative Three-Dimensional Mapping of Supraventricular Tachycardia in a Young Fontan Patient. (PubMed)

Intraoperative Three-Dimensional Mapping of Supraventricular Tachycardia in a Young Fontan Patient. Preoperative tachycardia is uncommon before an initial Fontan procedure. Catheter intervention can risk complications in small patients. A patient with fetal tachycardia and double inlet left ventricle underwent Norwood and bidirectional Glenn procedures. She had persistent tachycardia. A three-dimensional electroanatomic mapping system was modified for the operative procedure; it was used (...) to identify the arrhythmia substrate and cryoablate an atrioventricular nodal tachycardia. Mapping added 20 minutes to the operation. She is arrhythmia-free and off medication after 4 months. This three-dimensional system was successfully adapted for an intraoperative SVT ablation in this small patient, and it may be useful in other settings.Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

2017 Annals of Thoracic Surgery

28. Prenatal diagnosis and management of junctional ectopic tachycardia (PubMed)

Department of Medical Physics, University of Wisconsin, Biomagnetism Laboratory, Wisconsin Institutes for Medical Research, Madison, Wisconsin. eng Case Reports 2017 08 30 United States HeartRhythm Case Rep 101656239 2214-0271 Electrocardiography Fetal echocardiography Fetal magnetocardiography Fetal tachycardia Fetal treatment Fetus Hydrops fetalis Junctional ectopic tachycardia 2018 2 2 6 0 2018 2 2 6 0 2018 2 2 6 1 epublish 29387539 10.1016/j.hrcr.2017.07.022 S2214-0271(17)30148-3 PMC5778096 Prenat (...) Prenatal diagnosis and management of junctional ectopic tachycardia 29387539 2019 02 26 2214-0271 3 11 2017 Nov HeartRhythm case reports HeartRhythm Case Rep Prenatal diagnosis and management of junctional ectopic tachycardia. 503-508 10.1016/j.hrcr.2017.07.022 Zaidi S Javed SJ The Heart Institute for Children, Advocate Children's Hospital, Oak Lawn, Illinois. Siddiqui Saad S The Heart Institute for Children, Advocate Children's Hospital, Oak Lawn, Illinois. Rosalind Franklin School of Medicine

Full Text available with Trip Pro

2017 HeartRhythm Case Reports

29. Ventricular tachycardia in a neonate with prenatally diagnosed cardiac tumors: a case with tuberous sclerosis. (PubMed)

Ventricular tachycardia in a neonate with prenatally diagnosed cardiac tumors: a case with tuberous sclerosis. We report a patient with prenatally diagnosed tuberous sclerosis. Fetal ultrasonography demonstrated multiple cardiac tumors and arrhythmia. After birth, because of frequent supraventricular extrasystoles, the infant was admitted to the neonatal intensive care unit. Findings on 24-hour ambulatory electrocardiogram (ECG) showed frequent supraventricular tachycardia and ventricular (...) tachycardia with four beats as the longest run. At the age of 12 days, he developed cardiopulmonary arrest after crying out. A monitored ECG showed ventricular tachycardia. Twenty minutes after onset, a 12-lead ECG showed ventricular fibrillation, which returned to normal sinus rhythm with repeated DC cardioversion. Oral antiarrhythmic therapy with carteolol hydrochloride was effective. The patient showed no further symptoms after oral medication was initiated and the tumors regressed spontaneously.

2017 Pediatric Cardiology

30. Fetal dysrhythmias. (PubMed)

Fetal dysrhythmias. Fetal dysrhythmias are common abnormalities, usually manifesting as irregular rhythms. Although most irregularities are benign and caused by isolated atrial ectopics, in a few cases, rhythm irregularity may indicate partial atrioventricular block, which has different etiological and prognostic implications. We provide a flowchart for the initial management of irregular rhythm to help select cases requiring urgent specialist referral. Tachycardias and bradycardias are less (...) frequent, can lead to hemodynamic compromise, and may require in utero therapy. Pharmacological treatment of tachycardia depends on the type (supraventricular tachycardia or atrial flutter) and presence of hydrops, with digoxin, flecainide, and sotalol being commonly used. An ongoing randomized trial may best inform about their efficacy. Bradycardia due to blocked bigeminy normally resolves spontaneously, but if it is due to established complete heart block, there is no effective treatment. Ongoing

2019 Best practice & research. Clinical obstetrics & gynaecology

31. Lack of fetal effect from adenosine administration in a pregnant patient. (PubMed)

Lack of fetal effect from adenosine administration in a pregnant patient. Supraventricular Tachycardias are the most common cardiac rhythm disturbances in pregnant patients. Adenosine is the recommended medication to treat these arrhythmias in part because the medication is projected to be metabolized prior to crossing the placenta and producing any fetal effects. Reported here is a case of a pregnant patient treated with adenosine in which the fetal heart activity was monitored through point (...) of care ultrasonography with documentation of no fetal impact from this medication. This is the first documentation of a lack of fetal effect from adenosine.Copyright © 2019 Elsevier Inc. All rights reserved.

2019 American Journal of Emergency Medicine

32. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial. (PubMed)

Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial. Standardized treatment of fetal tachyarrhythmia has not been established.This study sought to evaluate the safety and efficacy of protocol-defined transplacental treatment for fetal supraventricular tachycardia (SVT) and atrial flutter (AFL).In this multicenter, single-arm trial, protocol-defined transplacental treatment using digoxin, sotalol, and flecainide was performed for singleton pregnancies from 22 to <37 (...)  weeks of gestation with sustained fetal SVT or AFL ≥180 beats/min. The primary endpoint was resolution of fetal tachyarrhythmia. Secondary endpoints were fetal death, pre-term birth, and neonatal arrhythmia. Adverse events (AEs) were also assessed.A total of 50 patients were enrolled at 15 institutions in Japan from 2010 to 2017; short ventriculoatrial (VA) SVT (n = 17), long VA SVT (n = 4), and AFL (n = 29). One patient with AFL was excluded because of withdrawal of consent. Fetal tachyarrhythmia

2019 Journal of the American College of Cardiology Controlled trial quality: uncertain

33. Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia?

Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia? BestBets: Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia? Is Intravenous Adenosine Effective and Safe in Patients presenting with Unstable Paroxysmal Supraventricular Tachycardia? Report By: Dr.Adnan Gebril - StR in Emergency Medicine Search checked by Dr.Stephen Hawes - Consultant in Emergency (...) Medicine Institution: University Hospital of South Manchester Foundation NHS Trust Date Submitted: 1st March 2000 Date Completed: 23rd February 2012 Last Modified: 23rd February 2012 Status: Green (complete) Three Part Question In [patients with Unstable Paroxysmal Supraventricular Tachycardia] is [treatment with intravenous Adenosine] both [effective and safe]? Clinical Scenario A 40-year-old woman with known paroxysmal supraventricular tachycardia (PSVT) presents to the emergency department

2012 BestBETS

34. Diagnosis and Treatment of Fetal Cardiac Disease

Suspected cardiac abnormality on obstetric ultrasound >40 I/B At detection Repeat fetal echocardiography if abnormality is found or if progressive disease is suspected Rhythm abnormalities: Tachycardia , 1% for associated CHD I/C At detection Fetal echocardiography to ascertain the mechanism of tachycardia and to guide therapy Bradycardia/CHB 50–55 I/C At detection Fetal echocardiography to ascertain mechanism of bradycardia, and if persistent, monitoring to assess heart rate, rhythm and cardiac (...) function Irregular rhythm 0.3% with CHD;2% with arrhythmia (0-0.7) I/C (frequent)IIa/C (persistent > 1-2 wks) At detection1–2 wk after detection Baseline fetal echocardiography and if persistent weekly heart rate monitoring until resolved to assess for tachycardia Noncardiac abnormality 20–45 I/B At detection Risk depends on organ systems affected ( ) Known or suspected chromosomal abnormality Varies, may be as high as 90 I/C 12–14 wk and/or 18–22 wk See the Extracardiac Assessment of the Fetus

Full Text available with Trip Pro

2014 American Heart Association

35. Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: A systematic review. (PubMed)

Maternal thyrotropin receptor antibody concentration and the risk of fetal and neonatal thyrotoxicosis: A systematic review. In pregnant women with Graves' disease, maternal thyrotropin receptor antibodies (TRAb) can cross the placenta and induce fetal or neonatal thyrotoxicosis. Symptoms of fetal thyrotoxicosis are tachycardia, intrauterine growth restriction, and intra-uterine death. Recommendations on an upper limit of TRAb concentrations below which intensive fetal monitoring can be safely (...) omitted vary between different guidelines. The objective of this study was to define an evidence-based cutoff level for maternal TRAb necessitating additional fetal monitoring during pregnancy.A literature search was performed to identify studies on pregnant women with Graves' disease and fetal and/or neonatal thyrotoxicosis. Only studies that reported TRAb were included.From a total of 229 identified titles, 20 articles could be included in the analysis. A total of 53 cases of fetal and/or neonatal

2018 Thyroid

36. First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis. (PubMed)

First-Line Antiarrhythmic Transplacental Treatment for Fetal Tachyarrhythmia: A Systematic Review and Meta-Analysis. There is no consensus on the most effective and best tolerated first-line antiarrhythmic treatment for fetal tachyarrhythmia. The purpose of this systematic review and meta-analysis was to compare the efficacy, safety, and fetal-maternal tolerance of first-line monotherapies for fetal supraventricular tachycardia and atrial flutter.A comprehensive search of several databases (...) was conducted through January 2017. Only studies that made a direct comparison between first-line treatments of fetal tachyarrhythmia were included. Outcomes of interest were termination of fetal tachyarrhythmia, fetal demise, and maternal complications. Ten studies met inclusion criteria, with 537 patients. Overall, 291 patients were treated with digoxin, 137 with flecainide, 102 with sotalol, and 7 with amiodarone. Digoxin achieved a lower rate of supraventricular tachycardia termination compared

Full Text available with Trip Pro

2018 Journal of the American Heart Association

37. Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report (PubMed)

Fetal hyperthyroidism associated with maternal thyroid autoantibodies: A case report A 33-year-old Caucasian woman was referred at 24 + 3 weeks of gestation due to fetal tachycardia and hydrops. She had an uncomplicated pregnancy 16 years previously and was on levothyroxine after total thyroidectomy for Graves' disease 6 years previously, when she developed moderate exophthalmos. Laboratory evaluation revealed appropriate thyroid function for this time of gestation: thyroid stimulating hormone (...) (TSH) 1.7 μU/ml (1-3), fT4 18.53 pmol/l (12-22), with positive antibodies: anti-TPO 157 U/ml (<35), TSH receptor antibodies (TRAb) 171.95 U/l (<1.75). The diagnosis was fetal hyperthyroidism due to transplacental passage of stimulating maternal TRAb. Methimazole and digoxin were initiated. The patient remained euthyroid, with fT4 levels in the upper normal range. The fetus showed intrauterine growth retardation, oligohydramnios, aggravating hydrops, goiter with increased central vascularization

Full Text available with Trip Pro

2018 Case Reports in Women's Health

38. Catecholaminergic Polymorphic Ventricular Tachycardia in Pregnancy. (PubMed)

at 15 weeks of gestation. Her care involved a multidisciplinary team including cardiology, maternal-fetal medicine, obstetric nursing, cardiac nursing, and anesthesia. A simulation scenario was designed to prepare for cardiac events during labor. A term intrapartum cesarean delivery was performed for fetal indications.A multidisciplinary approach to the antepartum, intrapartum, and postpartum care of women with catecholaminergic polymorphic ventricular tachycardia is critical to a team-based (...) Catecholaminergic Polymorphic Ventricular Tachycardia in Pregnancy. Catecholaminergic polymorphic ventricular tachycardia is a genetic disorder in which ventricular tachycardia occurs in the absence of structural heart disease or a prolonged QT interval. If untreated, there is a high incidence of sudden cardiac death. Management of this cardiac condition during pregnancy merits a multidisciplinary approach.A nulliparous woman with catecholaminergic polymorphic ventricular tachycardia presented

2016 Obstetrics and Gynecology

39. Fetal Long QT Syndrome Manifested as Atrioventricular Block and Ventricular Tachycardia: A Case Report and a Review of the Literature. (PubMed)

Fetal Long QT Syndrome Manifested as Atrioventricular Block and Ventricular Tachycardia: A Case Report and a Review of the Literature. Fetal onset of congenital long QT syndrome (LQTS) is a rare manifestation, and prenatal diagnosis is difficult. This report describes a boy who presented with both atrioventricular (AV) block and ventricular tachycardia during the antenatal period. The early postnatal electrocardiogram showed prolongation of the QT interval and AV block, subsequently leading (...) to a polymorphic ventricular tachycardia torsade de pointes. This unique feature of congenital LQTS has a poor outcome, but the boy was successfully treated with beta-blockers and implantation of an automated cardioverter-defibrillator. The intrauterine manifestation of fetal AV block and ventricular tachycardia should raise a high suspicion of congenital LQTS, and the strong association with a malignant clinical course should warrant special evaluation. The literature on the prenatal diagnosis, fetal therapy

2012 Pediatric Cardiology

40. Fetal Tachycardia

Fetal Tachycardia Fetal Tachycardia Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Fetal Tachycardia Fetal Tachycardia Aka: Fetal (...) Tachycardia , FHR Tachycardia From Related Chapters II. Definition >160 bpm III. Mild Fetal Tachycardia (FHR 160-180 bpm) Usually benign if normal Other causes Maternal fever, dehydration or anxiety Maternal ketosis Medications s (e.g. ) medications (e.g. ) Fetal movement Preterm Fetus Maternal Maternal IV. Significant Fetal Tachycardia (FHR >180 bpm) (especially if maternal fever) Fetal arrhythmia or congenital defect (FHR >200 bpm) V. References Bailey (2000) ALSO, E:1-13 Gabbe (2002) Obstetrics, p. 395

2015 FP Notebook

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>